NEA Management Company’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

NEA Management Company’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-65,374	Closed	-$503K	–	61
2022 Q2	$503K	Sell	65,374 -102,234	-61%	-$818K	0.03%	56
2022 Q1	$1.57M	Sell	167,608 -209,308	-56%	-$1.87M	0.05%	54
2021 Q4	$2.61M	Sell	376,916 -149,747	-28%	-$1.26M	0.05%	53
2021 Q3	$5.01M	Hold	526,663	–	–	0.06%	55
2021 Q2	$5.27M	Hold	526,663	–	–	0.07%	56
2021 Q1	$6.16M	Hold	526,663	–	–	0.14%	53
2020 Q4	$18.8M	Hold	526,663	–	–	0.5%	36
2020 Q3	$7.28M	Hold	526,663	–	–	0.31%	43
2020 Q2	$8.69M	Hold	526,663	–	–	0.35%	32
2020 Q1	$4.48M	Buy	+526,663	New	+$7.36M	0.23%	41

Other funds holding LUMO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

NEA Management Company's LUMO Position: Q3 2022 in Review

NEA Management Company sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2022, closing a stake of 65,374 shares — an estimated $503K sold.

NEA Management Company first reported a position in LUMO in Q1 2020 and held it in 10 quarters. The position peaked at $18.8M in Q4 2020. 35 funds tracked by Wall St. Rank hold LUMO as of Q3 2022.

NEA Management Company reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
NEA Management Company sold 65,374 Lumos Pharma, Inc. Common Stock shares in Q3 2022, an estimated $503K.
NEA Management Company first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2020 and held it in 10 quarters.
NEA Management Company's Lumos Pharma, Inc. Common Stock position peaked at $18.8M in Q4 2020.
35 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2022.

Based on NEA Management Company's 13F filing for Q3 2022, filed 14 Nov 2022.